Apellis Pharmaceuticals
APLS
#3073
Rank
A$7.34 B
Marketcap
A$57.46
Share price
0.10%
Change (1 day)
82.35%
Change (1 year)

Market capitalization of Apellis Pharmaceuticals (APLS)

Market cap: A$7.34 Billion

As of April 2026 Apellis Pharmaceuticals has a market cap of A$7.34 Billion. This makes Apellis Pharmaceuticals the world's 3073th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Apellis Pharmaceuticals from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026A$7.34 B55.73%
2025A$4.71 B-27.83%
2024A$6.53 B-37.23%
2023A$10.41 B23.91%
2022A$8.40 B32.34%
2021A$6.34 B12.7%
2020A$5.63 B101.48%
2019A$2.79 B165.37%
2018A$1.05 B-24.68%
2017A$1.39 B

End of Day market cap according to different sources

On Apr 9th, 2026 the market cap of Apellis Pharmaceuticals was reported to be:

A$7.33 Billion
by Nasdaq info icon info icon
A$7.33 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
A$1.60 B-78.17%๐Ÿ‡บ๐Ÿ‡ธ USA